EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Oral or pulse glucocorticoid use at the onset of giant cell arteritis and its influence on the risk of relapse: a retrospective study

Laura Trives-Folguera iD, Juan Molina-Collada iD, Katerine López iD, Javier Rivera iD, Belén Serrano-Benavente iD, Ana M Anzola-Alfaro iD, Isabel Castrejón iD, José María Álvaro-Gracia iD, Julia Martínez-Barrio iD

Rheumatology International · 2023

DOI: 10.1007/s00296-023-05321-6 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Rheumatology International, 2023. Verfasst von Laura Trives-Folguera und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Calle del Dr. Esquerdo, 46, 28007, Madrid, Spain. triveslaura@gmail.com. Hauptthemen laut MEDLINE: Glucocorticoids, Giant Cell Arteritis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objective is to investigate whether initial therapy with intravenous methylprednisolone pulses (ivMTP) or oral glucocorticoid (OG) influences the relapse rate in giant cell arteritis (GCA) patients. This is a retrospective observational study of patients with GCA from 2004 to 2021. Demographics, clinical and laboratory variables, cumulative glucocorticoid dose and relapse rate at 6-month follow-up defined according to EULAR recommendations were recorded. Univariate and multivariate logistic regression models were used to determine possible risk factors for relapse. A total of 74 GCA patients were included for analysis (54 (73%) female, mean (SD) age 77.2 (7.4) years). Overall, 47 (63.5%) patients received ivMTP at disease onset and 27 (36.5%) OG. Mean (SD) cumulative prednisone dose (mg) at 6-month follow-up was 3790.7 (1832.7) for patients with ivMTP vs 4298.1 (2930.6) for the OG group, p = 0.37. A total of 15 (20.3%) relapses occurred at 6-month follow-up. Relapse rates did not differ according to the initial therapy (19.1 vs 22.2%, respectively, p = 0.75). In the multivariate analysis, fever at disease onset (OR 4.837; CI 1.1-21.6) and dyslipidemia (OR 5.651; CI 1.1-28.4) were independent predictors for relapse. Initial therapy with ivMTP or OG does not influence the relapse rate of GCA patients. Fever at disease onset and dyslipidemia are independent predictors of disease relapse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucocorticoidsGiant Cell ArteritisHumansFemaleAgedMaleRetrospective StudiesPrednisoneMethylprednisoloneChronic DiseaseRecurrence

Stichwörter der Autor:innen

Giant cell arteritisGlucocorticoidMethylprednisolone pulsesRelapseVasculitis

Substanzen

GlucocorticoidsPrednisoneMethylprednisolone

Autor:innen und Institutionen

  • Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Calle del Dr. Esquerdo, 46, 28007, Madrid, Spain. triveslaura@gmail.com.
  • Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Calle del Dr. Esquerdo, 46, 28007, Madrid, Spain.
  • Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.

ORCID-Profile: Laura Trives-Folguera, Juan Molina-Collada, Katerine López, Javier Rivera, Belén Serrano-Benavente, Ana M Anzola-Alfaro, Isabel Castrejón, José María Álvaro-Gracia, Julia Martínez-Barrio

Zitieren

APA

Trives-Folguera, L., Molina-Collada, J., López, K., Rivera, J., Serrano-Benavente, B., Anzola-Alfaro, A. M., Castrejón, I., Álvaro-Gracia, J. M., & Martínez-Barrio, J. (2023). Oral or pulse glucocorticoid use at the onset of giant cell arteritis and its influence on the risk of relapse: a retrospective study. Rheumatology International. https://doi.org/10.1007/s00296-023-05321-6

Vancouver

Trives-Folguera L, Molina-Collada J, López K, Rivera J, Serrano-Benavente B, Anzola-Alfaro AM, et al. Oral or pulse glucocorticoid use at the onset of giant cell arteritis and its influence on the risk of relapse: a retrospective study. Rheumatology International. 2023. doi:10.1007/s00296-023-05321-6

BibTeX
@article{TrivesFolguera2023,
  author = {Trives-Folguera, Laura and Molina-Collada, Juan and López, Katerine and Rivera, Javier and Serrano-Benavente, Belén and Anzola-Alfaro, Ana M and Castrejón, Isabel and Álvaro-Gracia, José María and Martínez-Barrio, Julia},
  title = {Oral or pulse glucocorticoid use at the onset of giant cell arteritis and its influence on the risk of relapse: a retrospective study},
  journal = {Rheumatology International},
  year = {2023},
  doi = {10.1007/s00296-023-05321-6}
}
Kostenlos starten →